v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Commercialization revenue $ 98,149 $ 27,357
Costs and operating expenses:    
Cost of commercialization revenue 20,439 1,985
Research and development expenses 27,433 45,506
General and administrative expenses 11,475 11,113
Total costs and operating expenses 59,347 58,604
Income (loss) from operations 38,802 (31,247)
Other income (expense), net:    
Interest income 236 604
Interest expense (1,017) (1,153)
Other income (expense), net (11) 68
Total other income (expense), net (792) (481)
Income (loss) before provision for (benefit from) income taxes 38,010 (31,728)
Provision for (benefit from) income taxes 0 24
Net income (loss) 38,010 (31,752)
Other comprehensive gain (loss):    
Unrealized gain (loss) on available-for-sale securities (8) 149
Comprehensive income (loss) $ 38,002 $ (31,603)
Basic (loss) earnings per common share $ 3.53 $ (5.65)
Diluted (loss) earnings per common share $ 3.5 $ (5.65)
Basic weighted-average shares outstanding 10,764 5,623
Diluted weighted-average shares outstanding 10,851 5,623

Source